title: Effect of arachidonic acid metabolites on CR1 expression by B-lymphocytes.
abstract: The effect of arachidonic acid metabolites on the expression of the receptor for the C3b/C4b fragment of complement (CR1) by human B-lymphocytes was investigated. Kinetic experiments to determine CR1 expression over time indicated that the maximal receptor number occurred at 2 h, followed by a return to baseline values. Addition of 10(-4) M puromycin to the cells suggested that the increase was due to the expression of an intracellular pool and not de novo synthesis of new receptor molecules. B-lymphocytes were incubated with arachidonic acid, 15-hydroxyeicosatetraenoic acid, leukotrienes B4 or C4 or prostaglandin E2 (PGE2). The quantity of membrane antigenic binding sites was determined before and after incubation. The lipoxygenase metabolites did not alter CR1 numbers. In contrast, PGE2 significantly decreased (P less than 0.05) the quantity of CR1 expressed. In kinetic experiments, PGE2 blocked the maximal expression of CR1 seen at 2 h, indicating that it prevents the appearance of an intracellular pool of receptor. These results show that CR1 number on B-lymphocytes can be altered by at least one arachidonic acid metabolite. This may offer a partial explanation for the inhibitory effects of PGE2 on B-cell proliferation and immunoglobulin secretion since CR1 is implicated in B-lymphocyte differentiation and specific antibody response.
authors.affiliation: Groupe de Recherches en Immunologie et Biochimie, Faculté de Medecine, Limoges, France.
authors.forename: J M
authors.initials: JM
authors.lastname: Cook
authors.forename: F
authors.initials: F
authors.lastname: Guibert
authors.forename: S
authors.initials: S
authors.lastname: Delebassee
authors.forename: N
authors.initials: N
authors.lastname: Gualde
mesh_terms: D001095:Arachidonic Acids / Q000378:metabolism*; D001402:B-Lymphocytes / Q000378:metabolism; D015232:Dinoprostone / Q000494:pharmacology; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000494:pharmacology; D007700:Kinetics; D007975:Leukotriene B4 / Q000494:pharmacology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011951:Receptors, Complement / Q000096:biosynthesis*; D017463:Receptors, Complement 3b; D013189:SRS-A / Q000494:pharmacology
chemical_list: D001095:Arachidonic Acids; D006893:Hydroxyeicosatetraenoic Acids; D011500:Protein Synthesis Inhibitors; D011951:Receptors, Complement; D017463:Receptors, Complement 3b; D013189:SRS-A; D007975:Leukotriene B4; C025984:15-hydroxy-5,8,11,13-eicosatetraenoic acid; D015232:Dinoprostone